Entries by Maren Kühr

Experienced CEO appointed

Lori A. Ball has been appointed as the new Chief Executive Officer of UK-based Astoriom. She will be responsible for driving the development of Astoriom’s sample management business in the US, UK and Europe.

Where has the conviction gone?

2023 was another particularly tumultuous year for life sciences and, although the lingering effects of the last year are unlikely to change dramatically, the stabilisation of interest rates (off 16-year highs) and emerging direction of travel (market data points) tilt our bias to positive for the new year. 

Interims CEO takes over

In November 2023, Enhanc3D Genomics appointed Dr Hazel Jones as interim CEO and COO. Now she has taken over the Position of CEO officially.

Cancer research on three pillars

Over the past few years, the Frankfurt Institute of Clinical Cancer Research (IKF) has successfully conducted over 90 clinical studies. Each year, it enrolls approximately 1,500 patients in these trials. European Biotechnology spoke with the founder and director Prof. Dr med. Salah-Eddin Al-Batran.